Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 18, 2007Clinical and Vaccine ImmunologyOpen Access

Recombinant Protein-Based Assays for Detection of Antibodies to Severe Acute Respiratory Syndrome Coronavirus Spike and Nucleocapsid Proteins

View Full Paper
Ask AI
Bookmark
Share

Authors

LHLia M. HaynesCenters for Disease Control and PreventionCMCongrong MiaoNanjing Agricultural UniversityJHJennifer L. HarcourtCenters for Disease Control and Prevention

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Haynes et al. (2007) studied this question.

synapsesocial.com/papers/6ab21b40f8eeea9254ff45e8https://doi.org/10.1128/cvi.00351-06
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome2003 · 4,549 citations
  2. 2Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome2003 · 4,791 citations
  3. 3An Exposed Domain in the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Induces Neutralizing Antibodies2004 · 82 citations
  4. 4False-Positive Results in a Recombinant Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) Nucleocapsid-Based Western Blot Assay Were Rectified by the Use of Two Subunits (S1 and S2) of Spike for Detection of Antibody to SARS-CoV2006 · 44 citations
  5. 5Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA2004 · 71 citations